Conformational effects in the p53 protein of mutations induced during chemical carcinogenesis: molecular dynamic and immunologic analyses.
The tumor suppressor gene p53 has been identified as the most frequent target of genetic alterations in human cancers. Vinyl chloride, a known human carcinogen that induces the rare sentinel neoplasm angiosarcoma of the liver, has been associated with specific A-->T transversions at the first base of codons 249 and 255 of the p53 gene. These mutations result in an Arg-->Trp amino acid substitution at residue 249 and an Ile-->Phe amino acid substitution at residue 255 in a highly conserved region in the DNA-binding core domain of the p53 protein. To determine the effects of these substitutions on the three-dimensional structure of the p53 protein, we have performed molecular dynamics calculations on this core domain of the wild-type and the Trp-249 and Phe-255 mutants to compute the average structures of each of the three forms. Comparisons of the computed average structures show that both mutants differ substantially from the wild-type structure in certain common, discrete regions. One of these regions (residues 204-217) contains the epitope for the monoclonal antibody PAb240, which is concealed in the wild-type structure but accessible in both mutant structures. In order to confirm this conformational shift, tumor tissue and serum from vinyl chloride-exposed individuals with angiosarcomas of the liver were examined by immunohistochemistry and enzyme-linked immunosorbent assay. Individuals with tumors that contained the p53 mutations were found to have detectable mutant p53 protein in their tumor tissue and serum, whereas individuals with tumors without mutations and normal controls did not.
Brandt-Rauf
P W
PW
Division of Environmental Health Sciences, Columbia University School of Public Health, New York, New York 10032, USA.
Chen
J M
JM
Marion
M J
MJ
Smith
S J
SJ
Luo
J C
JC
Carney
W
W
Pincus
M R
MR
D000911:Antibodies, Monoclonal / Q000276:immunology / Q000378:metabolism; D002274:Carcinogens, Environmental / Q000494:pharmacology*; D018360:Crystallography, X-Ray; D004797:Enzyme-Linked Immunosorbent Assay; D000939:Epitopes / Q000737:chemistry; D006801:Humans; D007150:Immunohistochemistry; D008099:Liver / Q000378:metabolism; D008958:Models, Molecular; D016296:Mutagenesis / Q000235:genetics*; D010649:Phenylalanine / Q000235:genetics; D011487:Protein Conformation; D017434:Protein Structure, Tertiary; D014364:Tryptophan / Q000235:genetics; D016159:Tumor Suppressor Protein p53 / Q000737:chemistry* / Q000187:drug effects; D014752:Vinyl Chloride / Q000494:pharmacology*
D000911:Antibodies, Monoclonal; D002274:Carcinogens, Environmental; D000939:Epitopes; D016159:Tumor Suppressor Protein p53; D010649:Phenylalanine; D014364:Tryptophan; D014752:Vinyl Chloride